Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionBCJ Capital Management, LLC
Latest Disclosed Ownership17,994 shares
Latest Disclosed Value $ 1,847,440
BCJ Capital Management, LLC reports 596.90% increase in ownership of ABL / Abbott Laboratories

On May 13, 2026 - BCJ Capital Management, LLC filed a 13F-HR form disclosing ownership of 17,994 shares of Abbott Laboratories (DE:ABL) valued at $1,598,227 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 4, 2026 disclosing 2,582 shares of Abbott Laboratories. This represents a change in shares of 596.90% during the quarter. The current value of the position is $1,353,509 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F ABBOTT LABORATORIES COM 002824100 17,994 15,412 596.90 1,847 471.83 0.0981
2026-02-04 2025-12-31 13F ABBOTT LABS COM 002824100 2,582 257 11.05 323 3.86 0.0187
2025-10-31 2025-09-30 13F ABBOTT LABS COM 002824100 2,325 -7,266 -75.76 311 -76.15 0.0185
2025-08-13 2025-06-30 13F ABBOTT LABS COM 002824100 9,591 -514 -5.09 1,304 -2.69 0.0874
2025-04-30 2025-03-31 13F ABBOTT LABS COM 002824100 10,105 344 3.52 1,340 21.38 0.0969
2025-02-13 2024-12-31 13F ABBOTT LABS COM 002824100 9,761 2,531 35.01 1,104 33.98 0.0824
2024-11-14 2024-09-30 13F ABBOTT LABS COM 002824100 7,230 1,084 17.64 824 29.15 0.0617
2024-08-12 2024-06-30 13F ABBOTT LABS COM 002824100 6,146 1,252 25.58 639 14.75 0.0507
2024-05-14 2024-03-31 13F ABBOTT LABS COM 002824100 4,894 4,894 556 0.0440
2023-11-14 2023-09-30 13F ABBOTT LABS COM 002824100 0 -1,998 -100.00 0 -100.00
2023-08-14 2023-06-30 13F ABBOTT LABS COM 002824100 1,998 1,998 218 0.0192
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.